Comments on
Janssen Launches Healthy Minds Initiative with $3 Million


Last week, Janssen Pharmaceuticals announced an interesting partnership with the International Mental Health Research Organization (IMHRO) to support One Mind for Research with $3 million in funding. One Mind for Research a program of IMHRO that fosters neuroscience research, education, and awareness-building programs.

Janssen is the developer and manufacturer of a number of psychiatric medications, including Concerta, Invega, and Risperdal. Janssen is a division of Johnson & Johnson.

As part of the Healthy Minds efforts, Janssen will become the first private-sector partner to support the One Mind for Research program, which was started by former U.S. Congressman Patrick Kennedy and Garen Staglin, Vice President, Board of Directors, IMHRO.

 

Join the Conversation!

We invite you to share your thoughts and tell us what you think in this public forum. Before posting, please read our blog moderation guidelines. A first name or pseudonym is required and will be displayed with your comment. Your email address is also required, but will be kept private. (Please note that we use gravatars here, which are tied to your email address.) A website/blog/twitter address is optional.

Post a Comment: